Adaptive mechanisms of Campylobacter jejuni to erythromycin treatment

BACKGROUND: Macrolide is the drug of choice to treat human campylobacteriosis, but Campylobacter resistance to this antibiotic is rising. The mechanisms employed by Campylobacter jejuni to adapt to erythromycin treatment remain unknown and are examined in this study. The transcriptomic response of C...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Xia, Qingqing, Muraoka, Wayne T, Shen, Zhangqi, Sahin, Orhan, Wang, Hongning, Wu, Zuowei, Liu, Peng, Zhang, Qijing
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2013
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3694039/
https://ncbi.nlm.nih.gov/pubmed/23767761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2180-13-133
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi